Location History:
- Ymittos Attiki, GR (2015)
- Ymittos Attikis, GR (2017)
Company Filing History:
Years Active: 2015-2017
Title: Innovations of Alexandre Vamvakides
Introduction
Alexandre Vamvakides is a notable inventor based in Ymittos Attikis, Greece. He has made significant contributions to the field of neuroprotection and cancer treatment through his innovative patents. With a total of two patents to his name, Vamvakides is recognized for his work in developing therapeutic compositions that address critical health issues.
Latest Patents
Vamvakides' latest patents include ANAVEX2-73 and a composition involving certain anticholinesterase inhibitors for neuroprotection. This invention focuses on a dosage form that contains a therapeutically neuroprotective amount of A2-73, combined with at least one cooperating acetylcholinesterase inhibitor. The inhibitors are selected from a group that includes donepezil, galantamine, rivastigmine, or memantine. Additionally, he has developed sigma receptor ligands that exhibit both anti-apoptotic and pro-apoptotic properties. These ligands are designed to have anti-cancer activity and provide cytoprotective effects against degenerative diseases.
Career Highlights
Vamvakides is associated with Anavex Life Sciences Corp., a company dedicated to advancing innovative therapies for neurodegenerative diseases. His work has been instrumental in the development of new treatment options that aim to improve patient outcomes.
Collaborations
One of his notable collaborators is Tangui Maurice, with whom he has worked on various projects related to his patents and innovations.
Conclusion
Alexandre Vamvakides is a prominent inventor whose work in neuroprotection and cancer treatment has the potential to make a significant impact on healthcare. His innovative patents reflect his commitment to advancing medical science and improving the quality of life for patients.